Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study

NCT04883229 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04883229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
November 30, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral variant of frontotemporal dementia, corticobasal degeneration, nonfluent aphasia, progressive, primary progressive non fluent aphasia, primary progressive nonfluent aphasia, progressive supranuclear palsy